217 related articles for article (PubMed ID: 31684956)
1. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
Schmitz R; Adam MA; Blazer DG
World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
[TBL] [Abstract][Full Text] [Related]
2. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
[TBL] [Abstract][Full Text] [Related]
3. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
[TBL] [Abstract][Full Text] [Related]
4. Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma.
Adam MA; Moris D; Behrens S; Nussbaum DP; Jawitz O; Turner M; Lidsky M; Blazer D
Anticancer Res; 2019 Apr; 39(4):2007-2014. PubMed ID: 30952744
[TBL] [Abstract][Full Text] [Related]
5. Association Between Travel Distance, Hospital Volume, and Outcomes Following Resection of Cholangiocarcinoma.
Beal EW; Mehta R; Hyer JM; Paredes A; Merath K; Dillhoff ME; Cloyd J; Ejaz A; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):944-952. PubMed ID: 30815777
[TBL] [Abstract][Full Text] [Related]
6. The center volume-outcome effect in pancreas transplantation: a national analysis.
Kim Y; Dhar VK; Wima K; Jung AD; Xia BT; Hoehn RS; Diwan TS; Shah SA
J Surg Res; 2017 Jun; 213():25-31. PubMed ID: 28601322
[TBL] [Abstract][Full Text] [Related]
7. Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?
Schneider EB; Ejaz A; Spolverato G; Hirose K; Makary MA; Wolfgang CL; Ahuja N; Weiss M; Pawlik TM
J Gastrointest Surg; 2014 Dec; 18(12):2105-15. PubMed ID: 25297443
[TBL] [Abstract][Full Text] [Related]
8. Traveling to Receive Treatment for Extremity Soft Tissue Sarcomas: Is it worth the drive?
Vidri RJ; Raut CP; Fitzgerald TL
World J Surg; 2021 Aug; 45(8):2415-2425. PubMed ID: 33891137
[TBL] [Abstract][Full Text] [Related]
9. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
Speicher PJ; Englum BR; Ganapathi AM; Wang X; Hartwig MG; D'Amico TA; Berry MF
Ann Surg; 2017 Apr; 265(4):743-749. PubMed ID: 28266965
[TBL] [Abstract][Full Text] [Related]
10. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
[TBL] [Abstract][Full Text] [Related]
11. Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.
Beal EW; Mehta R; Merath K; Tsilimigras DI; Hyer JM; Paredes A; Dillhoff ME; Cloyd J; Ejaz A; Pawlik TM
J Gastrointest Surg; 2019 Jul; 23(7):1425-1434. PubMed ID: 31069637
[TBL] [Abstract][Full Text] [Related]
12. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Lopez Ramos C; Brandel MG; Steinberg JA; Wali AR; Rennert RC; Santiago-Dieppa DR; Sarkar RR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2019 Jan; 141(1):159-166. PubMed ID: 30460629
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Surgical Volume on Outcomes and Cost in Cleft Repair: A Kids' Inpatient Database Analysis.
Bucknor A; Chattha A; Wu W; Egeler S; Ultee K; Afshar S; Lin SJ
Ann Plast Surg; 2018 Apr; 80(4 Suppl 4):S174-S177. PubMed ID: 29672335
[TBL] [Abstract][Full Text] [Related]
14. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ
Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer.
Xia L; Taylor BL; Mamtani R; Christodouleas JP; Guzzo TJ
Urology; 2018 Apr; 114():87-94. PubMed ID: 29305205
[TBL] [Abstract][Full Text] [Related]
16. Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?
Klooster B; Rajeev R; Chrabaszcz S; Charlson J; Miura J; Bedi M; Gamblin TC; Johnston F; Turaga KK
J Surg Oncol; 2016 Jun; 113(7):823-7. PubMed ID: 27060344
[TBL] [Abstract][Full Text] [Related]
17. The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample.
Idrees JJ; Kimbrough CW; Rosinski BF; Schmidt C; Dillhoff ME; Beal EW; Bagante F; Merath K; Chen Q; Cloyd JM; Ellison EC; Pawlik TM
J Gastrointest Surg; 2018 Oct; 22(10):1688-1696. PubMed ID: 29855870
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.
Wilkinson KH; Ethun CG; Hembrook M; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Weber S; Gamblin TC; Cardona K; Clarke CN
J Surg Res; 2019 Jan; 233():154-162. PubMed ID: 30502242
[TBL] [Abstract][Full Text] [Related]
19. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
20. Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.
Nazzani S; Preisser F; Bandini M; Marchioni M; Tian Z; Soulières D; Montanari E; Ratti D; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Oncol; 2018 Sep; 1(4):346-351. PubMed ID: 31100257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
